Facet joint inflammation is linked to a more than threefold increase in the risk for subsequent ankylosis at the same spinal location in patients with axial spondyloarthritis (axSpA). Researchers ...
NEW YORK--(BUSINESS WIRE)--Xalud Therapeutics, a clinical-stage biotechnology company developing DNA-delivered therapeutics, today announced the first patient dosed in a Phase 2a clinical trial of its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback